TL;DR CNBC

Radioligand therapy, a 'game-changer' for cancer treatment, forces manufacturers to race against a ticking clock

Publishing timestamp: 2023-02-11 10:00:01

Summary

Radioligand therapy is a targeted form of cancer treatment that delivers radiation directly to cancer cells. Novartis is a pharmaceutical company that produces two radioligand therapy treatments called Lutathera and Pluvicto. The process of manufacturing the treatments is complex and time-sensitive, and the treatments are expensive. Patients who have received the treatments have reported positive results, and Novartis is working to improve access and awareness of the treatments.

Sentiment: POSITIVE

Tickers: NOV.N-CH,  NVS, 

Keywords: business news,  novartis ag,  science,  technology,  pharmaceuticals,  health care industry, 

Source: https://www.cnbc.com/2023/02/11/radioligand-cancer-therapy-forces-manufacturers-to-race-the-clock.html